View in EDS

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.

Saved in:
Bibliographic Details
Title: 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.
Authors: Weiner DM; ACADIA Pharmaceuticals Inc., San Diego, California 92121, USA. dweiner@acadia-pharm.com, Burstein ES, Nash N, Croston GE, Currier EA, Vanover KE, Harvey SC, Donohue E, Hansen HC, Andersson CM, Spalding TA, Gibson DF, Krebs-Thomson K, Powell SB, Geyer MA, Hacksell U, Brann MR
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2001 Oct; Vol. 299 (1), pp. 268-76.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print Cited Medium: Print ISSN: 0022-3565 (Print) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 11561089
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Weiner+DM%22">Weiner DM</searchLink>; ACADIA Pharmaceuticals Inc., San Diego, California 92121, USA. dweiner@acadia-pharm.com<br /><searchLink fieldCode="AU" term="%22Burstein+ES%22">Burstein ES</searchLink><br /><searchLink fieldCode="AU" term="%22Nash+N%22">Nash N</searchLink><br /><searchLink fieldCode="AU" term="%22Croston+GE%22">Croston GE</searchLink><br /><searchLink fieldCode="AU" term="%22Currier+EA%22">Currier EA</searchLink><br /><searchLink fieldCode="AU" term="%22Vanover+KE%22">Vanover KE</searchLink><br /><searchLink fieldCode="AU" term="%22Harvey+SC%22">Harvey SC</searchLink><br /><searchLink fieldCode="AU" term="%22Donohue+E%22">Donohue E</searchLink><br /><searchLink fieldCode="AU" term="%22Hansen+HC%22">Hansen HC</searchLink><br /><searchLink fieldCode="AU" term="%22Andersson+CM%22">Andersson CM</searchLink><br /><searchLink fieldCode="AU" term="%22Spalding+TA%22">Spalding TA</searchLink><br /><searchLink fieldCode="AU" term="%22Gibson+DF%22">Gibson DF</searchLink><br /><searchLink fieldCode="AU" term="%22Krebs-Thomson+K%22">Krebs-Thomson K</searchLink><br /><searchLink fieldCode="AU" term="%22Powell+SB%22">Powell SB</searchLink><br /><searchLink fieldCode="AU" term="%22Geyer+MA%22">Geyer MA</searchLink><br /><searchLink fieldCode="AU" term="%22Hacksell+U%22">Hacksell U</searchLink><br /><searchLink fieldCode="AU" term="%22Brann+MR%22">Brann MR</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 2001 Oct; Vol. 299 (1), pp. 268-76.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0022-3565 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=11561089
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 268
    Titles:
      – TitleFull: 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Weiner DM
      – PersonEntity:
          Name:
            NameFull: Burstein ES
      – PersonEntity:
          Name:
            NameFull: Nash N
      – PersonEntity:
          Name:
            NameFull: Croston GE
      – PersonEntity:
          Name:
            NameFull: Currier EA
      – PersonEntity:
          Name:
            NameFull: Vanover KE
      – PersonEntity:
          Name:
            NameFull: Harvey SC
      – PersonEntity:
          Name:
            NameFull: Donohue E
      – PersonEntity:
          Name:
            NameFull: Hansen HC
      – PersonEntity:
          Name:
            NameFull: Andersson CM
      – PersonEntity:
          Name:
            NameFull: Spalding TA
      – PersonEntity:
          Name:
            NameFull: Gibson DF
      – PersonEntity:
          Name:
            NameFull: Krebs-Thomson K
      – PersonEntity:
          Name:
            NameFull: Powell SB
      – PersonEntity:
          Name:
            NameFull: Geyer MA
      – PersonEntity:
          Name:
            NameFull: Hacksell U
      – PersonEntity:
          Name:
            NameFull: Brann MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2001 Oct
              Type: published
              Y: 2001
          Identifiers:
            – Type: issn-print
              Value: 0022-3565
          Numbering:
            – Type: volume
              Value: 299
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The Journal of pharmacology and experimental therapeutics
              Type: main
ResultId 1